PMC:7253482 / 213-316 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":73,"end":80},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"}],"text":"ens with high fatality rates and pandemic potential. Vaccine development focuses on the principal targe"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T31","span":{"begin":4,"end":8},"obj":"IN"},{"id":"T32","span":{"begin":9,"end":13},"obj":"JJ"},{"id":"T33","span":{"begin":14,"end":22},"obj":"NN"},{"id":"T34","span":{"begin":23,"end":28},"obj":"NNS"},{"id":"T35","span":{"begin":29,"end":32},"obj":"CC"},{"id":"T36","span":{"begin":33,"end":41},"obj":"JJ"},{"id":"T37","span":{"begin":42,"end":51},"obj":"NN"},{"id":"T38","span":{"begin":53,"end":60},"obj":"NN"},{"id":"T39","span":{"begin":61,"end":72},"obj":"NN"},{"id":"T40","span":{"begin":73,"end":80},"obj":"VBZ"},{"id":"T41","span":{"begin":81,"end":83},"obj":"IN"},{"id":"T42","span":{"begin":84,"end":87},"obj":"DT"},{"id":"T43","span":{"begin":88,"end":97},"obj":"JJ"}],"relations":[{"id":"R29","pred":"arg2Of","subj":"T35","obj":"T31"},{"id":"R30","pred":"arg1Of","subj":"T34","obj":"T32"},{"id":"R31","pred":"arg1Of","subj":"T34","obj":"T33"},{"id":"R32","pred":"arg1Of","subj":"T34","obj":"T35"},{"id":"R33","pred":"arg2Of","subj":"T37","obj":"T35"},{"id":"R34","pred":"arg1Of","subj":"T37","obj":"T36"},{"id":"R35","pred":"arg1Of","subj":"T39","obj":"T38"},{"id":"R36","pred":"arg1Of","subj":"T39","obj":"T40"},{"id":"R37","pred":"arg1Of","subj":"T40","obj":"T41"}],"text":"ens with high fatality rates and pandemic potential. Vaccine development focuses on the principal targe"}